10-Q quarterly report · filed Nov 5, 2026

Oscar Health, Inc. (OSCR) Q3 2026 10-Q Quarterly Report

Short answer

Oscar Health, Inc. (OSCR) filed its Q3 2026 10-Q quarterly report on Nov 5, 2026 for the quarter ended Sep 30, 2026. Quarterly revenue was $6M (down 28.5% year over year) with net income of $167M.

Q3 2026 key financials · XBRL

Revenue
$6M
−28.5% YoY · +3.3% QoQ
Net income
$167M
+221.7% YoY · −53.8% QoQ
Operating margin
2827.9%
EPS (diluted)
$0.43
+182.7% YoY · −60.6% QoQ

Source: XBRL data from the Oscar Health, Inc. (OSCR) Q3 2026 10-Q on SEC EDGAR. USD.

Oscar Health, Inc. Q3 2026 10-Q analysis

AI summary of MD&A and risk factor updates

Management Discussion & Analysis

  • Revenue $5.14B, up 72% YoY from $2.99B, driven by rate increases and higher membership
  • MLR 84.0% vs 88.5% YoY, SG&A ratio 14.0% vs 17.5%
  • Individual and Small Group membership 2.69M vs 2.11M, up 27% YoY
  • Operating cash flow $3.5B for nine months vs $423.0M YoY, investment purchases drove $1.8B investing outflow
  • eAPTC expiration and enrollment-integrity rules threaten membership, with tariffs risking higher medical costs and MLR

Risk Factors

  • No material changes to risk factors from the December 31, 2025 Form 10-K
  • Carried-forward regulatory risk: compliance obligations under health insurance laws
  • Carried-forward market risk: competition affecting membership growth and pricing
  • Carried-forward financial risk: operating losses and capital requirements affecting liquidity

Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K

Other Oscar Health, Inc. quarterly reports

Ask about this quarter

Compare quarters, check guidance or see what insiders and funds did around the report.